You are here: Home » News-CM » Companies » Results
Business Standard

Fredun Pharmaceuticals standalone net profit declines 40.35% in the December 2019 quarter

Capital Market 

Sales decline 0.11% to Rs 26.23 crore

Net profit of Fredun Pharmaceuticals declined 40.35% to Rs 1.02 crore in the quarter ended December 2019 as against Rs 1.71 crore during the previous quarter ended December 2018. Sales declined 0.11% to Rs 26.23 crore in the quarter ended December 2019 as against Rs 26.26 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales26.2326.26 0 OPM %9.4512.45 -PBDT1.502.68 -44 PBT1.022.35 -57 NP1.021.71 -40

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, February 13 2020. 11:50 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU